Optimization and simplification of transcatheter aortic valve implantation therapy

References

• Barbanti M, Webb JG, Gilard M, et al. Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention. 2017;13:AA11–AA21.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791.
   Web of Science ®Google Scholar
• Binder RK, Webb JG, Willson AB, et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol. 2013;62:431–438.
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113–118.
   PubMed Web of Science ®Google Scholar
• Jabbour A, Boshell D, Sesel K, et al. Inducible myocardial ischaemia diagnosed using computed tomography dipyridamole stress myocardial perfusion technique. J Med Imaging Radiat Oncol. 2012;56:445–448.
   PubMed Web of Science ®Google Scholar
• Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2012;6:366–380.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;63:e57–185.
   PubMed Web of Science ®Google Scholar
• Otto CM, Kumbhani DJ, Alexander KP, et al. ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis. J Am Coll Cardiol. 2017 Mar 14;69(10):1313–1346.
   PubMed Web of Science ®Google Scholar
• Chieffo A, Giustino G, Spagnolo P, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2015 Jul;8(7):e002025. doi: 10.1161/circinterventions.114.002025.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Todaro D, Costa G, et al. Optimized screening of coronary artery disease with invasive coronary angiography and Ad Hoc percutaneous coronary intervention during transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017 Aug;10(8):e005234. in press.
   Web of Science ®Google Scholar
• Barbash IM, Barbanti M, Webb J, et al. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36:3370–3379.
   PubMed Web of Science ®Google Scholar
• Ando T, Briasoulis A, Holmes AA, et al. Percutaneous versus surgical cut-down access in transfemoral transcatheter aortic valve replacement: A meta-analysis. J Card Surg. 2016;31:710–717.
   PubMed Web of Science ®Google Scholar
• Billings FT, Kodali SK, Shanewise JS. Transcatheter aortic valve implantation: anesthetic considerations. Anesth Analg. 2009;108:1453–1462.
   PubMed Web of Science ®Google Scholar
• Brown JM, O’Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the society of thoracic surgeons national database. J Thorac Cardiovasc Surg. 2009;137:82–90.
   PubMed Web of Science ®Google Scholar
• Dehedin B, Guinot PG, Ibrahim H, et al. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036–1043.
   PubMed Web of Science ®Google Scholar
• Attizzani GF, Ohno Y, Latib A, et al. Transcatheter aortic valve implantation under angiographic guidance with and without adjunctive transesophageal echocardiography. Am J Cardiol. 2015;116:604–611.
   PubMed Web of Science ®Google Scholar
• Greif M, Lange P, NäBauer M, et al. Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart. 2014;100:691e695.
   Web of Science ®Google Scholar
• Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5:461e467.
   Web of Science ®Google Scholar
• Grube E, Naber C, Abizaid A, et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. J Am Coll Cardiol Intv. 2011;4:751–757.
   Google Scholar
• Bijuklic K, Haselbach T, Witt J, et al. Increased risk of cerebral embolization after implantation of a balloon-expandable aortic valve without prior balloon valvuloplasty. JACC Cardiovasc Interv. 2015;8:1608–1613.
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18–23.
   PubMed Web of Science ®Google Scholar
• Gabriel M, Pawlaczyk K, Waliszewski K, et al. Location of femoral artery puncture site and the risk of postcatheterization pseudoaneurysm formation. Int J Cardiol. 2007;120:167—71.
   PubMed Web of Science ®Google Scholar
• Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65:196—202.
   PubMed Web of Science ®Google Scholar
• Vavuranakis M, Kalogeras K, Vrachatis D, et al. Inferior epi-gastric artery as a landmark for transfemoral TAVI. Optimizing vascular access? Catheter Cardiovasc Interv. 2013;81:1061—6.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Binder RK, Freeman M, et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention. 2013;9:929–935.
   PubMed Web of Science ®Google Scholar
• Lauck SB, Wood DA, Baumbusch J, et al. Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circ Cardiovasc Qual Outcomes. 2016;9:312–321.
   PubMed Web of Science ®Google Scholar
• Généreux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;60:1043—52.
   PubMed Web of Science ®Google Scholar
• van der Boon RM, Nuis RJ, van Mieghem NM, et al. New conduction abnormalities after TAVI–frequency and causes. Nat Rev Cardiol. 2012;9:454–463.
   PubMed Web of Science ®Google Scholar
• Roten L, Meier B. Left bundle branch block after transcatheter aortic valve implantation: still a matter of concern? JACC Cardiovasc Interv. 2014;7:137–139.
   PubMed Web of Science ®Google Scholar
• Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129:1233–1243.
   PubMed Web of Science ®Google Scholar
• Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER trial and registry. JACC Cardiovasc Interv. 2015;8:60–69.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Gulino S, Costa G, et al. Pathophysiology, incidence and predictors of conduction disturbances during transcatheter aortic valve implantation. Expert Rev Med Devices. 2017;14:2, 135–147.
   PubMed Web of Science ®Google Scholar
• Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J. 2014;35:2639–2654.
   PubMed Web of Science ®Google Scholar
• Siontis GC, JüNi P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVI: a meta-analysis. J Am Coll Cardiol. 2014;64:129–140.
   PubMed Web of Science ®Google Scholar
• Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3:524–530.
   PubMed Web of Science ®Google Scholar
• Schroeter T, Linke A, Haensig M, et al. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace. 2012;14:1759–1763.
   PubMed Web of Science ®Google Scholar
• Jr BJ, Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J. 2010;159:497–503.
   PubMed Web of Science ®Google Scholar
• Toutouzas K, Synetos A, Tousoulis D, et al. Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: the role of a new echocardiographic index. Int J Cardiol. 2014;172:601–603.
   PubMed Web of Science ®Google Scholar
• Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15:1070–1118.
   PubMed Web of Science ®Google Scholar
• Biner S, Michowitz Y, Leshem-Rubinow E, et al. Hemodynamic impact and outcome of permanent pacemaker implantation following transcatheter aortic valve implantation. Am J Cardiol. 2014;113:132–137.
   PubMed Web of Science ®Google Scholar
• Schwerg M, Baldenhofer G, Dreger H, et al. Complete atrioventricular block after TAVI: when is pacemaker implantation safe? Pacing Clin Electrophysiol. 2013;36:898–903.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Capranzano P, Ohno Y, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015;101:1485–1490.
   PubMed Web of Science ®Google Scholar
• Urena M, Hayek S, Cheema AN, et al. Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement. Circulation. 2015;131:469–477.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement: the PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in transcatheter aortic valve implantation). JACC Card Inter. 2015;12:1595–1604.
   Google Scholar
• Reynolds MR, Lei Y, Wang K, et al. CoreValve US high risk pivotal trial investigators. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67:29–38.
   PubMedGoogle Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (placement of aortic transcatheter valves) trial (Cohort A). J Am Coll Cardiol. 2012;60:2683–2692.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Magnuson EA, Wang K, et al. PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125:1102–1109.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Baron SJ, Cohen DJ. Economic implications of transcatheter aortic valve replacement in patients at intermediate surgical risk. Circulation.2016;134:1416–1418.
   Google Scholar
• Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Baan J, Spence MS, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry. BMC Cardiovasc Disord. 2017 Oct 10;17(1):259. DOI:10.1186/s12872-017-0693-0
   PubMedGoogle Scholar
• Wood DA, The Vancouver multidisciplinary, multimodality, but minimalist clinical pathway facilitates safe next day discharge home at low, medium, and high volume transcatheter aortic valve replacement centres: the 3M TAVR study. Presented at TCT 2017, Denver, US, Oct 30, 2017.
   Google Scholar
• Barbanti M, Buccheri S, Rodés-Cabau J, et al. Transcatheter aortic valve replacement with new-generation devices: a systematic review and meta-analysis. Int J Cardiol. 2017;245:83–89.
   PubMed Web of Science ®Google Scholar